Lorillard
Addiction Research Foundation
Fields
- Author
- Granston, A.
- Area
- SPEARS/EVPOR
- Alias
- 01403358/01403380
- Type
- REPT, OTHER REPORT
- CHAR, CHART/GRAPH
- Site
- G65
- Named Person
- Bryant, T.E.
- Bunney, W.E.
- Califano
- Freedman, D.X.
- Goldstein, A.
- Hamburg, D.
- Lee, P.R.
- Bunney, W.E.
- Date Loaded
- 05 Jun 1998
- Document File
- 01403257/01403574/H J Stevens Legal 78
- Request
- R1-004
- R1-072
- R1-132
- R1-072
- Named Organization
- Addiction Research Foundation
- Carnegie
- Drug Abuse Council
- Ford
- Hew, Dept of Health Education and Welfare
- Kaiser
- Nas, Natl Academy of Sciences
- Natl Institute of Drug Abuse
- Natl Inst of Mental Health
- Salk Inst
- Stanford Univ
- Univ Ca
- Univ Chicago
- Carnegie
- Characteristic
- UNCO, UNCODED LIST
- Litigation
- Stmn/Produced
- Master ID
- 01403358/3380
- UCSF Legacy ID
- axa91e00
Document Images
.
.
4
"The National Institute of Drug Abuse in H.E.W. considers the
Addiction Research Foundation to be the most productive, solid
such organization in the world."
Alan Cranston, U.S. Senator
State of California

T
:
L
CONTENTS
Page
Purposes & Goals of the Foundation 1-5
Accomplishments of the Foundation 6
History and Achievements 7
Commendations 8
Justification of Support 9
Funding and Donations 10-13
Conclusion 14
Boards of the Foundation
National Advisory Council
15
Scientific Advisory Board' 16
Board of Directors 17
Board of Associates 18
Articles of Interest - 19-20

The Addiction Research Foundation? Why?
The Addiction Research Foundation was established by Dr. Avram Goldstein
in 1974 to discover the physiological causes of Narcotics and Tobacco
Addiction.
Problem I: NARCOTICS ADDICTION
NARCOTICS ADDICTION...
is a problem for at least 500,000 U.S. citizens and is increas-
ing throughout the world.
costs people of the U.S. between $10 and $17 billion each year.
has not been restrained by campaigns to educate the public of
the dangers of drug abuse nor by government intervention--less
than 1% of all imported heroin is confiscated.
has a very low addict rehabilitation rate, less than 25% by all
known methods.
*1*

What CouMbe Done?
If NARCOTICS ADDICTION were eliminatzd...
... an estimated 500,000 heroin addicts could be effectively re-
habilitated.
... crime in the streets could be reduced.
... the staggering monetary costs in law enforcement efforts,
drug rehabilitation, prison confinement, and enforcement of
narcotics laws could be substantially reduced.
*2*

Problem II: TOBACCO ADDICTION
TOBACCO ADDICTION'...
... is the greatest single cause of death and illness of all the
addictive diseases. An untold number of illnesses and 300,000
deaths each year are caused by smoking. -
... costs the U.S. an estimated $42 billion annually (22 per cent
of the Gross National Product).
... has not been prevented by education campaigns nor government
restrictions. (Consumption in 1976 increased from 599 billion
to 608 billion cigarettes.)
... has a very low rehabilitation rate, 10% by all known~methods.
*3*

What Could Be Done?
If TOBACCO ADDICTION were eliminated...
... 300,000 persons would not die prematurely each year.
... there would be 85% fewer deaths from bronchitis or emphysema,
one-third fewer deaths from artherioscierosis, one-third'
fewer from heart disease, 90% fewer from cancer of the trachea
and lungs, and 50% fewer from cancer of the bladder.
.., one in six Americans now alive, more than 37 million, will
die from cigarette smoking years before they otherwise would.
*t,*

s
r
Why The Addiction Research Foundation
The Addiction Research Foundation is seeking the physiological basis
for Narcotics and Tobacco Addiction. Research is based on the premise
that only by learning the reasons for these addiction will evolve
truly effective methods of prevention and treatment.
*5*

What Has the Addiction Research Foundation Accomplished?
The Foundation...
... has discovered that humans produce naturally in~their pitu-
itary glands a substance - called endorphin -_that acts
precisely like heroin and other opiates. Endorphin is a
pain-killer. It appears to be part of a natural defense
mechanism against stress and seems to influence emotions
and personality traits. It may possibly relate to mental
illness. Insufficient production may be the reason some
persons are vulnerable to addiction. It may also be the
reason withdrawal from addiction is so difficult.
... has developed a method for measuring endorphin in human
blood to determine what constitutes a normal supply and the
effect of an insufficient or excessive amount.
... is experimenting with more effective methods of drug re-
habilitation, including a new, non-addictive substance--
naltrexone--tha:t blocks the effects of heroin.
.., has begun a pilot study into the physiological causes of
nicotine addiction. Very little research has been done in
this area.
... believes that the results of research into nicotine an&nar-
cotics addiction will lead to effective methods of prevention
and rehabilitation.
*6*

.
1974
1975
1976
1977
1978
The Foundation - History and Achievements
* Founded by Dr. Avram Goldstein, Professor and former
Chairman of Pharmacology at Stanford University for 15
years.
* Discovered endorphin--a hormone produced in the human
pituitary gland'which acts precisely like heroin.
* Participated in testing of two new methods of rehabili-
tating narcotics addicts, one of which completely blocks
the effects of heroin.
* Developed a method to analyze the amount of endorphin in
human blood to determine what is a normal and an abnormal
supply.
* Commenced a pilot program to learn the physiological causes
of tobacco addiction.
* Testing the blood of narcotics addicts and non-addicts to
determine if an imbalance of endorphin causes vulne.ability
to narcotics addiction, excessive emotional disorders, re-
action to rain,_and deviations in personality.
* Seeking additional endorphins in the pituitary gland.
* Planning the expansion of the Tobacco Addiction Research
into a major program.
All programs of the Addiction Research Foundation are reviewed annually
by an eminent Scientific Advisory Board whose members are listed in
this brochure. (See page 16)
*7*

Commendations
"Dr. Goldstein and his colleagues in Palo Alto have earned, and continue
to hold, the highest reputation for competence and first-rate work."
Thomas E. Bryant, M.D.
President's Commission on
Mental Health
President, Drug Abuse Council
"Avram Goldstein is one of the truly remarkable contemporary scientists.
He is an outstanding leader not only in pharmacology, but in the bio-
medical sciences generally."
David Hamburg, M.D., President
Institute of Medicine
National Academy of Sciences
"As a Director of the Drug Abuse Council (a foundation funded by'Ford,
Carnegie, Kaiser, etc.), I had the opportunity to review the only grant
we were able to give to what can be assessed as the leading biological
sciences potential in the country. That grant went to Dr. Goldstein
who clearly is a brilliant scientist and leader in the field...in terms
of integrity and clarity of purpose, I believe you will find few to
match the Addiction Research.Foundation."
Daniel X. Freedman, M.D.
Professor and Chairman
Department of Psychiatry
The University of Chicago
"'Dr. Avram Goldstein, who directs the Addiction Research Foundation, is
one of the most creative scientists in the United States working in the
field of addiction research. He has made significant contributions to
our understanding of addiction."
Philip R. Lee, M~.D.
Professor of Social Medicine
University of California, S.F.
Former Asst. Secretary, HEW
*8*

.
Why The Addiction Research Foundation Needs Your Help
* To build a science laboratory for research on the
physiological causes of Tobacco Addiction.
* To continue research on Narcotics Addiction --
prevention and rehabilitation.
* To accelerate research on the bodily influence of
endorphin -- its impact on pain reaction, excessive
tension, and other emotional disturbances, including
mental illness.
*9*

.
0
*How Much Money Is Needed?
Total for ._.$600,000
Constuction of Tobacco Addiction
Research Laboratory................... $300,000
"Start-up" Equipment for
Laboratory............................ .$100,000
Implementation of Narcotics
Addiction Program (Equipment,
Personnel, Emergency Needs,
Development) .......................... $200,000
Total ................. $600,000
A total of $400,000 for Tobacco Laboratory development
would be the beginning of a major program in an area
where little has been done. The additional $200,000
could assure the acceleration of a program that has in
a short time produced findings that appear to relate
significantly to narcotics addiction, and possibly fo
stress, pain, and mental illness.
*Major funding -- Annual grants from H.E.W. -- approxi-
mately $1,200,0001to support a staff of 45 persons and
a program of 40 narcotics addicts - volunteers for
testing scientific findings and new methods of rehabili-
tation.
*10*

Why Extra Funds Are Needed
* When findings are made by scientists, new equip-
ment, personnel and materials are frequently
neede&, which could not have been anticipated.
When government grants are requested to satisfy
these unexpected needs, research efforts are
stalemated'for up to 15 months until a decision
is made by H.E.W.
To assure a continuous and accelerated research
program, it is essential that a fund be established
to meet these needs as they arise.
* Funds for construction of a tobacco research lab-
oratory are not available from the government.
Private sources are an imperative.
* Raising $400,000 is a prerequisite to procuring
H.E.W. grants for a major research program on tobacco
addiction.
*11*

What Is The Urgency To Raise Funds Now?
* The Foundation's pilot program on tobacco addiction has pro-
gressed to a point where a science laboratory is essential
now to provide space for a major program and continued pro-
gress.
* Delays in construction of a laboratory now result in increased
inflationary costs later.
* H.E.W.'s Secretary Califano has stressed the urgency and nec-
essity for government support of research: in~tobacco addiction.
Major research funds are available now if a science laboratory
can be constructed from private funds.
* The monetary and human cost to society of tobacco and narcotics
addiction is staggering. A relatively small amount of money
spent in research now could save billions in prevention and
cure.
*12*.

What Is The Projected Plan For Donations?
Cumulative
1 Donation .............$100,000 $100,000
3 Donations ............ 50,000 250,000
6 " ............ 25,000 400,000
10 " ............ 10,000 500,000
15 '' ............ 5,000 575,000
20 ............Below 5,000 600,000
Contributions are tax deductible under Section 170,
Internal Revenue Code. The Addiction Research~Founda-
tion is a 509(a)(1) organization under the tax Ref-rm
Act of 1969.
*13*

0
Conclusion
* Two of the greatest burdens of the nation are Narcotics and
Tobacco Addiction.
* Current methods of dealing with these problems are relatively
ineffective.
* The Addiction Research Foundation has made findings which
appear not only to be basic to combating narcotics addiction
but also has made findings which relate to the problems of
physical pain, stress, personality traits and human emotions.
* The Foundation has started a pilot program in tobacco addic-
tion. With~your help it could develop into a major research
program to find the physiological causes of tobacco addiction.
* With your help the Foundation could be assured a continuous
and accelerated program of research on narcotics addiction
by providing for equipment, personnel and other needs as they
arise.
* Dr. Avram Goldstein is considered by his peers to be one of
the nation's most outstanding scientists in the field of addic-
tive diseases. The Foundation is considered by'private pro-
fessional persons and government officials as being one of the
foremost organizations of its kind.
* Every person pays a horrendous price directly or indirectly
for the problems to the solution of which the Addiction Re-
search Foundation is dedicated. Each of us can play a very
vital role in combating these burdens of society.
*lt,*

IN
Y
National Advisory Council
Thomas E. Bryant
Executive Director, President's
Cormnission on Mental Health
Mrs. Douglas Cater
Special Asst. to President
Aspen Institute
Honorable Alan Cranston
U.S. Senator
State of California
Vincent P. Dole, K.D..
Professor, Rockefeller University
Dr. Charles Edwards -
Former Commissioner of Health, FDA
President, Scripps Clinic and
Research Foundation
Daniel X. Freedman
Professor and Chairman
Department of Psychiatry
David A. Hamburg, M.D.
President, Institute of Medicine
National Academy of Sciences
Philip R. Lee, M.D.
Former Asst. Secretary, H.E.W.
Director, Health Policy Program
University of California
Art Linkletter
Lay Leader
Mrs. Florence Mahoney
Lay Leader, National
Health Programs
Mrs. Nan Tucker McEvoy
Lay Leader, Fr-mer Presidential
Appointee to UiVESCO
Max i,. Palevsky
Industrialist
Joseph Slater
President, Aspen Institute
Honorable John Vasconcellos
Assemblyman
State of California
*15*

Scientific Advisory Board
Floyd E. Bloom, M.D., Director
Arthur V. Davis Center for Behavioral
Neurobiology
The Salk Institute
Doris H. Clouet, Ph.D.
Assistant Director
New York State Office of Drug Abuse Services
William M. Harvey, Ph.D., Director
Narcotics Service Council of St. Louis
Jerome H. Jaffe, M.D., Professor
Psychiatry
Columbia University
Harold Kalant, M.D., Ph.D., Professor
Pharmacology
University of Toronto
Jack H. Mendelsom, M.D., Professor
Psychiatry
Harvard Medical School
Norman Weiner, M.D., Professor
Chairman of Pharmacology
University of Colorado Medical Center
*16*

.
Board of Directors
Patricia E. Bashaw...Vice President, Resource Center
for Women
Herschel J. Brown...Director, First National Bank of
San Jose; Former Executive Vice-President, Lockheed
Missiles and Space Company
Leonard Cornell...Attorney; Realtor; Former Associate
Professor, Denver University Law School
Avram Goldstein...M.D.; Director and Founder of
Addiction Research Foundation; Former Chairman of
Pharmacology, Stanford University
Catherine Lee...Attorney; Board of Directors, KQED
Joseph~0ren...M.D.; Director on Immunology and
Respirato.y Di:..:ase, Syntex Research; Clinical
Assistant, Professor, Stanford University
Joseph Schmedding...Retired Executive Vice-President,
Bank of America; Former member of Trustees Committee,
San Francisco Foundation
Vartan Ghazarossian...Postdoctoral Fellow in Laboratory
Research, Addiction Research Foundation
Henry P. Organ...Associate General Secretary,, Stanford
University
Martin E. Packard...Ph.D.; Corporate Vice-President,
Varian Associates; Former Trustee, San Francisco
Foundation
Wilbur Watkins...Management Consultant; Former Presi-
dent, General Paint Corporation; Former Executive
Administrator, Palo Alto Medical Clinic
Philip N. B1iss...Special Counselor/Consultant, Palo
Alto Unified School District; Consultant to California
State Department of Education
Donald E. Yost...Management Consultant; Former Operations
Manager, Fairchild Semiconductor
Charles G. Schultz...LegaI Counsel
*17*

BOARD OF ASSOCIATES
* Creighton Peet, President...Retired Vice President,
Safeway Stores, Inc.
Mrs. Alfred Bochner...Former President, Holbrook
Palmer Foundation; Member, Board of Directors,
UniomPacific Bank
Richard S. Dinner...Partner, Dinner Levison Company;
Vice-President, Graduate Theological Union
Mrs. Genevieve di San Faustino....Member, Board of
Trustees, The Bothin Helping Fund
Burnham Enersen...Partner, MeCutcheon, Doyle, Brown
and Enersen, Attorneys
David Faskin...Investments; Member of the Board,
California Association for A.C.T.
Peter Folger...Retired Chairman of the Board, Folger
Coffee Company
Crawford Greene, Jr...Partner, McCutcheon, Doyle,
Brown an&Enersen, Attorneys
Richard J. Guggenhime...Attorney, Heller, Ehrman,
White and'rlcAuliffe; Director, Institute of Medical
Sciences
John Huntington...Attorney; President, University
of California-Hastings Law Center Foundation
* Mrs. Charles B. Kuhn...Vice Chairman and Treasurer,
.San Francisco Foundation
Mrs. Matilda Manning Kunin...Civic Leader in many
Bay Area organizations
Francis A. Martin Jr...Advertising Consultant;
Board of Direc-tors, San Francisco Ecology Center
Edgar N. Meakin...Consultant
John F. Mi11er...President, Hunter, Miller and Fleming,
Estate Management
* Emmett Solomon...Retire&Chairman, Board of Directors,
Crocker National Bank 0
6-h
* Brooks Walker, Jr...Chairman, U.S. Leasing International, rCh
Inc.; Chairman, San Francisco Foundation 0
W
* Wilbur L. Watkins...Former President, General Paint ~
Corporatiom; Former Executive Administrator, Palo Alto 00Medical Clinic
* EXECUTIVE COMMITTEE MEMBERS

Excerpted from The New York Times
October 2, 1977
4piate-L~~e Substances in B
rain
MaYHold Clue to Pain and .Mo
0
Th di' cov oC i stmiiari...l
>ietw-rn substaitcei produc,ed by the hu
r+an hrstrr a-nA::hlr
the QDiLm yoooy has
-
--n realm of body chem=
istry, offering-ctuel to the nature of pain,
pleasure. the emotians and perhaps, such
mattars as-epilepay, drug addiction and '
me~tal Illaess.
The climactic finding. which has gen-{
erated a flurr}y of scientific effort;~ wasi
that the brain and the body"s master
gland, the, pituitsry, nukelthe.ir'own na-
tural substances that appear to.act like
morahi;+e aez opium derivative:
In the twoyears since that, discovery,
a whole nevK family of suctt substances !
has been ideatitied. They . are. called en-
~ dorphine, a::coioed word meaning "the
morphine within_"
Seldom hap a new-fidfdoU.biological
research stirred-such wideapreadexcite-
ment, sv swiftly. ThQ newly: discover
chemfcals .. are; ,at once, clues and toof
through chicb 'sciefltistt: hope to brin
into focus nsw vistas.of brarR-function,
"It ha= rTMatM a1 mtch e'csitGIIlent
neuroacience as. a;ny field`in- the Ias
u etades,' th.re is.ao
quesqo
at; _said. nr. witliam;.Bunne
F
,_
haLjjs;Jt
e
° g chemis
~QnSernin~ p~,. epi-
le23y. and eirnt2l ilin sa ar'-h ino deve(.
° _ . _ °
" o>:~tteatdng~ some
c~ a c°a
ac°a of a~hi Ooh[tn12 aild deDression
S
*19*

.
..M
r
Excerpted from The San Francisco Chronicle
June 16, 1976
Research Sdentsts iProbe
A MorphineLike -Hormone
BY Chart.s p.rit
stance, helos control the ser drive =
but the hor=ones now under study are
thouant to piay a muca more buot e
part in Laa ce ra e cttet^.t U tnterp[ay
t at tncyatew astects a person s per-
son Lr., z:^.u otnavior.
"It s one of ' the tncst frnrtfu1
Per3ocs our rne aS:;n, s r.
. e ti7n n=oac o[ the uvers,rv o_f
or-..u3_ en rer ere ~ a
t eeHuay meet.ag or e docrne
Society got under way at the Iiilton
HoteL
4fuch of the current activity cen- ~
ters on a neri y vd f
hormone, en orp w Iln
an tzst tu sru esoe aves muca e+
morpnine, even t ou its c ecuc3 ~'
,, r
any mownopta ~
* In' searching for other chetnirrls
which attach to the same sites, a r13ss of
smaTl ptoteisLs,, or peptides, was di'scov-
ered. lt was noticed that these peptides
were actuaily small sections of the
larger lipotropin earlier studied by Li..
Just in the past two years,'the
theory has been developed - backed up
by persuasive animal studies - that.
somehow production of lipottropin, or its
breakdown into the smaller endorphins,
plays a crucial role in controlling the.
brain's moods, emotions, and sensations
of pain_ _
Goldste[n. wbo ts also dirEctor of
the Addicnon Research Foundanon in
P o Alto, sa1 tn a te e one [ntervtew
t at in juat t e past iew montns in "
Ia bratory more morptune-tt' e' com-
p un nave aen coua tn antsnal
brams an p[tuitary btantts.
"We will robabl find a whole-
famll o t ese ormones. " he sai .' t
may weil lead to recoa_nanon of an
entue y new system or neura ' contro
Scientists at art international meet Later, largely because of wor's br
Inc here yesta ay escn bea growing pharmacoloezst Dr. . vrara ezn at
excitement over e recent discoverv of Stan2or n,versity an r°3earc ers at
a c.a5s of ^attiral nol'L7on!'S tsceGI to the ~ ucuLe tn JaD Ie;o, e
benave znuca Me morptund. soecifJc site9 [n brain nerve ce to
3lany hormones are hown to ~` ~ch moc-oatne artachey ~ere [ entf-
f ied.
contaroY tnood* - testosterone, for in.
-
*20*.

---
